EXPERIMENTAL IRRADIATION The Experimental Irradiation core provides for the use of radiation by the members of the University of Michigan Comprehensive Cancer Center. The services of this core are critical to users in the UMCCC, serving not only those interested in radiation biology and radiation therapy but also those for whom radiation is a tool. Thus, the facility serves a primary goal of the Cancer Center, supporting basic research and it translation to clinical applications. The irradiation core not only maintains and operates the irradiators but also consults with each investigator before initiation of a project so that the studies are carried out in the most efficient way possible. The experience of the director and manager allow them to offer investigators information on dosage and treatment regimens, particularly in animal studies, so that experimental resources are not wasted. Also, their experience allows them to foster interactions, because they connect investigators who have used radiation in various types of experiments over the last several years. Use of the Experimental Irradiation core by a wide variety of members of the Cancer Center is exemplified by the distribution of users. The 33 Cancer Center members who utilize the core participate in 12 Programs including Breast Oncology, Cancer Cell Biology, Molecular Therapeutics, Gastrointestinal Oncology, and Radiation Sciences, among others. In order to provide this vital service, the core maintains three irradiators. The primary irradiator is a Pantak Therapax DXT 300 orthovoltage unit which is used for irradiations of cell cultures and animals (primarily mice and rats, but also available for use with rabbits and dogs, as needed). The core maintains two 137-Cs irradiators. One is devoted to animal irradiations and is located in the specific pathogen free area of the mouse housing facility in ULAM. The availability of this unit allows investigators to perform irradiations without removing their immunodeficient mice from the quarantined facility. The other irradiator is for low dose rate (0.1-0.4 Gy/hour) irradiations. This irradiator, located within the Radiation Oncology department in the 1331 Ann Bldg is built inside a humidified CO2 incubator, permitting studies of chronic exposure to very low radiation doses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-23
Application #
8147788
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
23
Fiscal Year
2010
Total Cost
$60,060
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Manohar, Poorni M; Beesley, Lauren J; Bellile, Emily L et al. (2018) Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Nucl Med 43:641-647
Hawley, Sarah T; Li, Yun; An, Lawrence C et al. (2018) Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial. J Clin Oncol 36:659-666
Salami, Simpa S; Hovelson, Daniel H; Kaplan, Jeremy B et al. (2018) Transcriptomic heterogeneity in multifocal prostate cancer. JCI Insight 3:
Smith, Joshua; Kulkarni, Aditi; Birkeland, Andrew C et al. (2018) Whole-Exome Sequencing of Sinonasal Small Cell Carcinoma Arising within a Papillary Schneiderian Carcinoma In Situ. Otolaryngol Head Neck Surg 159:859-865
Eberl, Markus; Mangelberger, Doris; Swanson, Jacob B et al. (2018) Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma. Cancer Cell 33:229-243.e4
Lazarus, Jenny; Maj, Tomasz; Smith, J Joshua et al. (2018) Spatial and phenotypic immune profiling of metastatic colon cancer. JCI Insight 3:
Kim, Yeung-Hyen; Zhu, Lingqiao; Pyaram, Kalyani et al. (2018) PLZF-expressing CD4 T cells show the characteristics of terminally differentiated effector memory CD4 T cells in humans. Eur J Immunol 48:1255-1257
Davis, Elizabeth J; Griffith, Kent A; Kim, Edward J et al. (2018) A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers. Am J Clin Oncol 41:128-132
Mendiratta-Lala, Mishal; Masch, William; Shankar, Prasad R et al. (2018) MR Imaging Evaluation of Hepatocellular Carcinoma Treated with Stereotactic Body Radiation Therapy (SBRT): Long Term Imaging Follow-Up. Int J Radiat Oncol Biol Phys :
Tamura, Shuzo; Wang, Yin; Veeneman, Brendan et al. (2018) Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer. Bladder Cancer 4:77-90

Showing the most recent 10 out of 1493 publications